Urueña A - Search Results

1

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.

Postma M, Fisman D, Giglio N, Márquez-Peláez S, Nguyen VH, Pugliese A, Ruiz-Aragón J, Urueña A, Mould-Quevedo J. Postma M, et al. Among authors: uruena a. Vaccines (Basel). 2023 Jun 11;11(6):1089. doi: 10.3390/vaccines11061089. Vaccines (Basel). 2023. PMID: 37376478 Free PMC article. Review.

2

Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.

Urueña A, Vizzotti C, San Juan JA. Urueña A, et al. Vaccine. 2016 Jun 14;34(28):3222. doi: 10.1016/j.vaccine.2016.03.099. Vaccine. 2016. PMID: 27288997 No abstract available.

3

Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection.

Uruena A, Cassetti I, Kashyap N, Deleage C, Estes JD, Trindade C, Hammoud DA, Burbelo PD, Natarajan V, Dewar R, Imamichi H, Ward AJ, Poole A, Ober A, Rehm C, Jones S, Liang CJ, Chun TW, Nath A, Lane HC, Smith BR, Connors M, Migueles SA. Uruena A, et al. Open Forum Infect Dis. 2020 Dec 15;8(1):ofaa613. doi: 10.1093/ofid/ofaa613. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 33511235 Free PMC article.

4

Clinical ergotism induced by ritonavir.

Vila A, Mykietiuk A, Bonvehì P, Temporiti E, Urueña A, Herrera F. Vila A, et al. Among authors: uruena a. Scand J Infect Dis. 2001;33(10):788-9. doi: 10.1080/003655401317074699. Scand J Infect Dis. 2001. PMID: 11728055

5

HIV and pregnancy: maternal and neonatal evolution.

Cecchini D, Urueña A, Trinidad P, Vesperoni F, Mecikovsky D. Cecchini D, et al. Among authors: uruena a. Medicina (B Aires). 2011;71(5):432-6. Medicina (B Aires). 2011. PMID: 22057168

6

Impact of the single-dose immunization strategy against hepatitis A in Argentina.

Vizzotti C, González J, Gentile A, Rearte A, Ramonet M, Cañero-Velasco MC, Pérez Carrega ME, Urueña A, Diosque M. Vizzotti C, et al. Among authors: uruena a. Pediatr Infect Dis J. 2014 Jan;33(1):84-8. doi: 10.1097/INF.0000000000000042. Pediatr Infect Dis J. 2014. PMID: 24352191

7

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Giglio N, Gentile A, Jimenez SG, Jáuregui B, Clark AD, Diosque M, Vizzotti C. Urueña A, et al. Vaccine. 2011 Jul 12;29(31):4963-72. doi: 10.1016/j.vaccine.2011.04.111. Epub 2011 May 27. Vaccine. 2011. PMID: 21621575

8

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C. Urueña A, et al. Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074. Vaccine. 2015. PMID: 25919152

9

Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.

Nguyen VH, Vizzotti C, Uruena A, Giglio N, Magneres C, Richmond H. Nguyen VH, et al. Among authors: uruena a. Vaccine. 2020 Apr 29;38(20):3682-3689. doi: 10.1016/j.vaccine.2020.02.081. Epub 2020 Apr 2. Vaccine. 2020. PMID: 32249017 Free article.

10

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina.

Urueña A, Micone P, Magneres C, Mould-Quevedo J, Giglio N. Urueña A, et al. Vaccines (Basel). 2021 Apr 1;9(4):335. doi: 10.3390/vaccines9040335. Vaccines (Basel). 2021. PMID: 33916048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page